Here s Why Raptor Pharmaceuticals Corp #marketing #pharmaceuticals

Posted On Sep 8 2017 by

#raptor pharma # Here s Why Raptor Pharmaceuticals Corp. Plunged Today Sep 14, 2015 at 11:39AM What. Raptor Pharmaceuticals (NASDAQ:RPTP ). a small-cap biopharma company specializing in the development of treatments for rare diseases, saw its stock plunge by nearly 40% today on heavy volume. This massive downward move was precipitated by the announcement that the company’s experimental drug for nonalcoholic steatohepatitis (NASH) in children, RP103, failed to meet its primary endpoint in a second mid-stage trial. Because RP103 reportedly failed to make any meaningful impact on liver fibrosis, Raptor expects to discontinue the drug’s clinical program for NASH following …


Acxiom Lets Consumers See Data It Collects – The New York Times #data-mining #and #database #marketing,acxiom #corp,privacy,consumer #behavior,computer #security,advertising #and #marketing,federal #trade #commission,center #for #digital #democracy

Posted On Aug 14 2017 by

# Acxiom Lets Consumers See Data It Collects Scott Howe, chief of Acxiom, displayed his own information last week to demonstrate the company s consumer data portal. Credit Jacob Slaton for The New York Times Aboutthedata.com, a Web site introduced on Wednesday by a leading marketing technology firm called the Acxiom Corporation, is offering individual consumers a glimpse of some of the details the company has collected about them. Visitors who log in to the site may review many seemingly innocuous facts, such as whether someone in their household owns a dog or a cat, or is interested in jogging …


Stock trade online #ibm, #ibm #analyst #estimates, #ibm #earnings #estimates, #ibm #share #estimates, #ibm #analyst #recommendations, #ibm #ratings, #international #business #machines #corp. #analyst #estimates, #international #business #machines #corp. #earnings #estimates, #international #business #machines #corp. #analyst #recommendations, #international #business #machines #corp. #analyst #ratings

Posted On Aug 11 2017 by

# International Business Machines Corp. Jul. 19, 2017 at 5:14 p.m. ET by Victor Reklaitis U.S. stock-market indexes closed firmly higher Wednesday, with all of the main equity benchmarks notching records, as buying appetite resumed on Wall Street. The Dow Jones Industrial Average closed up 0.3% higher at 21,640, as big gains in shares of Boeing Co. and UnitedHealth Group Inc. –bouncing back from Tuesday s selling–helped to more than offset a 4.2% tumble in shares of International Business Machines Corp. which disappointed investors in second-quarter sales. IBM cut about 40 points from the price-weighted Dow, but the gauge still …


Raptor Pharmaceutical Corp #diamond #pharma

Posted On Aug 9 2017 by

#raptor pharma # Traders Salivating For Action In Raptor Pharma: Here Are The Facts Raptor Pharmaceutical Corp. (NASDAQ: RPTP ) is a bio-pharmaceutical company that focuses on the development of treatment for people affected by various diseases, including nephropathic cystinosis in adults and children. The stock was seeing some heavy buying action earlier this week on takeover chatter. Reuters said on April 6 Raptor has consulted with investment bankers and financial advisers to explore a potential sale. On Thursday, Bloomberg reported Retrophin, the company founded by Martin Shkreli, was said to be considering a takeover of Raptor Pharmaceutical. Raptor s …


Here s Why Raptor Pharmaceuticals Corp #pharma #iq

Posted On Aug 9 2017 by

#raptor pharma # Here s Why Raptor Pharmaceuticals Corp. Plunged Today Sep 14, 2015 at 11:39AM What. Raptor Pharmaceuticals (NASDAQ:RPTP ). a small-cap biopharma company specializing in the development of treatments for rare diseases, saw its stock plunge by nearly 40% today on heavy volume. This massive downward move was precipitated by the announcement that the company’s experimental drug for nonalcoholic steatohepatitis (NASH) in children, RP103, failed to meet its primary endpoint in a second mid-stage trial. Because RP103 reportedly failed to make any meaningful impact on liver fibrosis, Raptor expects to discontinue the drug’s clinical program for NASH following …


Raptor Pharmaceutical Corp #generic #drug #company

Posted On Aug 2 2017 by

#raptor pharma # Traders Salivating For Action In Raptor Pharma: Here Are The Facts Raptor Pharmaceutical Corp. (NASDAQ: RPTP ) is a bio-pharmaceutical company that focuses on the development of treatment for people affected by various diseases, including nephropathic cystinosis in adults and children. The stock was seeing some heavy buying action earlier this week on takeover chatter. Reuters said on April 6 Raptor has consulted with investment bankers and financial advisers to explore a potential sale. On Thursday, Bloomberg reported Retrophin, the company founded by Martin Shkreli, was said to be considering a takeover of Raptor Pharmaceutical. Raptor s …


Here s Why Raptor Pharmaceuticals Corp #industry #pharmacy

Posted On May 16 2017 by

#raptor pharma # Here s Why Raptor Pharmaceuticals Corp. Plunged Today Sep 14, 2015 at 11:39AM What. Raptor Pharmaceuticals (NASDAQ:RPTP ). a small-cap biopharma company specializing in the development of treatments for rare diseases, saw its stock plunge by nearly 40% today on heavy volume. This massive downward move was precipitated by the announcement that the company’s experimental drug for nonalcoholic steatohepatitis (NASH) in children, RP103, failed to meet its primary endpoint in a second mid-stage trial. Because RP103 reportedly failed to make any meaningful impact on liver fibrosis, Raptor expects to discontinue the drug’s clinical program for NASH following …


Raptor Pharmaceutical Corp #cafe #pharma #merck

Posted On May 16 2017 by

#raptor pharma # Traders Salivating For Action In Raptor Pharma: Here Are The Facts Raptor Pharmaceutical Corp. (NASDAQ: RPTP ) is a bio-pharmaceutical company that focuses on the development of treatment for people affected by various diseases, including nephropathic cystinosis in adults and children. The stock was seeing some heavy buying action earlier this week on takeover chatter. Reuters said on April 6 Raptor has consulted with investment bankers and financial advisers to explore a potential sale. On Thursday, Bloomberg reported Retrophin, the company founded by Martin Shkreli, was said to be considering a takeover of Raptor Pharmaceutical. Raptor s …


Raptor Pharmaceutical Corp #cafe #pharma #boards

Posted On Apr 21 2017 by

#raptor pharma # Traders Salivating For Action In Raptor Pharma: Here Are The Facts Raptor Pharmaceutical Corp. (NASDAQ: RPTP ) is a bio-pharmaceutical company that focuses on the development of treatment for people affected by various diseases, including nephropathic cystinosis in adults and children. The stock was seeing some heavy buying action earlier this week on takeover chatter. Reuters said on April 6 Raptor has consulted with investment bankers and financial advisers to explore a potential sale. On Thursday, Bloomberg reported Retrophin, the company founded by Martin Shkreli, was said to be considering a takeover of Raptor Pharmaceutical. Raptor s …


Here s Why Raptor Pharmaceuticals Corp #pharmaceutical #recruiters

Posted On Apr 12 2017 by

#raptor pharma # Here s Why Raptor Pharmaceuticals Corp. Plunged Today Sep 14, 2015 at 11:39AM What. Raptor Pharmaceuticals (NASDAQ:RPTP ). a small-cap biopharma company specializing in the development of treatments for rare diseases, saw its stock plunge by nearly 40% today on heavy volume. This massive downward move was precipitated by the announcement that the company’s experimental drug for nonalcoholic steatohepatitis (NASH) in children, RP103, failed to meet its primary endpoint in a second mid-stage trial. Because RP103 reportedly failed to make any meaningful impact on liver fibrosis, Raptor expects to discontinue the drug’s clinical program for NASH following …